Protective renal effect of dapagliflozin in type 2 diabetes

被引：0
|
作者：
Dobler, Gabriele
机构：
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2023年 / 18卷 / 01期
关键词：
D O I：
10.1055/a-1933-5902
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In vorhergehenden Studien wurde bereits nachgewiesen, dass Natrium-Glucose-Cotransporter-2-Inhibitoren (SGLT2-Inhibitoren) das Progressionsrisiko einer moderaten bis schweren albuminurischen Nierenerkrankung mindern. Mosenzon et al. untersuchten in einer Post-hoc-Analyse die Auswirkungen von Dapagliflozin auf die Verschlechterung der Nierenfunktion bei Typ-2-Diabetes. Der Fokus lag auf der Subpopulation von Patient/innen mit niedrigem renalem Risiko.
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [1] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Donald Elliott Kohan
    Paola Fioretto
    Kristina Johnsson
    Shamik Parikh
    Agata Ptaszynska
    Lisa Ying
    [J]. Journal of Nephrology, 2016, 29 : 391 - 400
  • [2] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Kohan, Donald Elliott
    Fioretto, Paola
    Johnsson, Kristina
    Parikh, Shamik
    Ptaszynska, Agata
    Ying, Lisa
    [J]. JOURNAL OF NEPHROLOGY, 2016, 29 (03) : 391 - 400
  • [3] Effect of Dapagliflozin on renal protection in patients with uncontrolled type 2 diabetes mellitus
    张德园
    [J]. China Medical Abstracts (Internal Medicine), 2020, 37 (01) : 21 - 22
  • [4] Renal effects of dapagliflozin in patients with type 2 diabetes
    Thomas, Merlin C.
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2014, 5 (03) : 53 - 61
  • [5] Renal Protective Effect of Metformin in Type 2 Diabetes Patients
    Wang, Hsi-Hao
    Lin, Sheng-Hsiang
    Hung, Shih-Yuan
    Chiou, Yuan-Yow
    Hsu, Wan-Chia
    Chang, Chih-Min
    Liou, Hung-Hsiang
    Chang, Min-Yu
    Ho, Li-Chun
    Wu, Ching-Fang
    Lee, Yi-Che
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [6] Effect of Dapagliflozin on renal and hepatic glucose kinetics in type 2 diabetes and NGT subjects
    Tripathy, D.
    Solis-Herrera, C.
    Chen, X.
    Hansis-Diarte, A.
    Chilton, R.
    DeFronzo, R.
    Cersosimo, E.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S7 - S7
  • [7] Nephro-protective effects of Dapagliflozin in patients with type 2 diabetes
    Nakayama, M.
    Tomiyama, H.
    Yakou, F.
    Iijima, Y.
    Tanaka, A.
    Shiina, K.
    Hirano, M.
    Uchiyama, T.
    Aizawa, Y.
    Odawara, M.
    Yamashina, A.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 3 - 3
  • [8] Effect of dapagliflozin on renal and cardiac function in patients with type 2 diabetes and albuminuria: a randomised study
    Eickhoff, M. K.
    Olsen, F. J.
    Frimodt-Moller, M.
    Diaz, L. J.
    Jensen, M. T.
    Rossing, P.
    Persson, F.
    [J]. DIABETOLOGIA, 2018, 61 : S299 - S300
  • [9] Effects of Dapagliflozin Therapy on Renal Hemodynamics in Type 2 Diabetes Patients
    Qin, Yuejuan
    Baskoy, Gozde
    Triplitt, Curtis L.
    Solis-Herrera, Carolina
    Adams, John M., III
    Defronzo, Ralph A.
    Cersosimo, Eugenio
    [J]. DIABETES, 2023, 72
  • [10] Dapagliflozin does not impact renal function in patients with type 2 diabetes
    Ptaszynska, A.
    Chalamandaris, A. -G.
    Sugg, J.
    Johnsson, K.
    Parikh, S.
    List, J. F.
    [J]. DIABETOLOGIA, 2012, 55 : S107 - S107
12345